Wellington Management Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$941K Buy
98,883
+12,363
+14% +$96K ﹤0.01% 1686
2025
Q4
$675K Sell
86,520
-7,010
-7% -$50.7K ﹤0.01% 1782
2025
Q3
$710K Buy
93,530
+6,752
+8% +$56.2K ﹤0.01% 1837
2025
Q2
$778K Sell
86,778
-4,570
-5% -$42.6K ﹤0.01% 1752
2025
Q1
$685K Buy
91,348
+2,291
+3% +$18.5K ﹤0.01% 1777
2024
Q4
$670K Sell
89,057
-18,763
-17% -$142K ﹤0.01% 1787
2024
Q3
$819K Buy
+107,820
New +$820K ﹤0.01% 1745
2020
Q1
Sell
-22,708
Closed -$78K 1915
2019
Q4
$78K Sell
22,708
-5,420
-19% -$13.6K ﹤0.01% 1997
2019
Q3
$80K Sell
28,128
-6,890
-20% -$21.4K ﹤0.01% 2008
2019
Q2
$133K Hold
35,018
﹤0.01% 2028
2019
Q1
$285K Buy
+35,018
New +$300K ﹤0.01% 1969
2017
Q2
Sell
-202,317
Closed -$1.7M 2204
2017
Q1
$1.7M Buy
+202,317
New +$1.41M ﹤0.01% 1779
2016
Q3
Sell
-256,120
Closed -$727K 2181
2016
Q2
$727K Sell
256,120
-1,240,739
-83% -$3.85M ﹤0.01% 1846
2016
Q1
$4.24M Sell
1,496,859
-5,973,580
-80% -$26.5M ﹤0.01% 1405
2015
Q4
$77.1M Sell
7,470,439
-31,497
-0.4% -$313K 0.02% 551
2015
Q3
$85.5M Buy
7,501,936
+520,365
+7% +$6.94M 0.02% 492
2015
Q2
$104M Sell
6,981,571
-38,712
-0.6% -$440K 0.03% 477
2015
Q1
$63.4M Sell
7,020,283
-368,990
-5% -$3.82M 0.02% 662
2014
Q4
$89.9M Buy
7,389,273
+1,529,847
+26% +$16.9M 0.02% 548
2014
Q3
$57.3M Buy
5,859,426
+510,081
+10% +$6.25M 0.02% 674
2014
Q2
$68.2M Buy
5,349,345
+1,329,584
+33% +$12.9M 0.02% 642
2014
Q1
$42.5M Sell
4,019,761
-771,469
-16% -$8.23M 0.01% 795
2013
Q4
$36.4M Buy
4,791,230
+2,159,640
+82% +$13.7M 0.01% 827
2013
Q3
$19.2M Buy
+2,631,590
New +$13.3M 0.01% 1014

Other funds holding BCRX